Clinical Trial Update: Fexofenadine in Patients With Active Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/Phase 2 study of fexofenadine in patients with active rheumatoid arthritis. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Fexofenadine (fexofenadine)

Snippet

Sponsor: October 6 University | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: RECRUITING